MARK2 and cancer: Mammalian target of rapamycin (mTOR), an evolutionarily conserved and ubiquitous serine/threonine kinase, plays a central role in regulating cell proliferation, apoptosis, autophagy and migration, being considered a hotspot target for cancer therapy [41].